Stockscreener 앱 받기
0.4029
6.78%
-0.0293
시장 영업 전:
.40
-0.0029
-0.72%
전일 마감가:
$0.4322
열려 있는:
$0.4364
하루 거래량:
614.01K
Relative Volume:
0.12
시가총액:
$2.64M
수익:
-
순이익/손실:
$-16.89M
주가수익비율:
-0.0193
EPS:
-20.8847
순현금흐름:
$-16.44M
1주 성능:
-2.89%
1개월 성능:
-3.47%
6개월 성능:
-77.49%
1년 성능:
-93.08%
1일 변동 폭
$0.39
$0.4364
1주일 범위
$0.39
$0.783
52주 변동 폭
$0.25
$14.14
Glucotrack Inc Stock (GCTK) Company Profile
명칭
Glucotrack Inc
전화
972 (8) 675-7878
주소
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.4029 | 1.99M | 0 | -16.89M | -16.44M | -20.88 |
ISRG
Intuitive Surgical Inc
|
393.38 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.63 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
73.63 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
220.05 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
33.81 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
Glucotrack Inc 주식(GCTK)의 최신 뉴스
GlucoTrack Restructures Debt Through Equity-Linked Note Exchange - TipRanks
GlucoTrack Creates $900,000 Partitioned Note, Enables Exchanges Into Stock at Market-Based Price - TradingView
Glucotrack (NASDAQ: GCTK) creates $900,000 exchangeable note for stock - Stock Titan
GlucoTrack Inc (GCTK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GlucoTrack Inc (GCTK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GlucoTrack Inc (GCTK) Income Statement - TradingKey
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
TradingKey - TradingKey
GlucoTrack Inc (GCTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GlucoTrack Inc (NASDAQ: GCTK) Stock Price, News & Analysis - Kalkine
GCTK|GlucoTrack Inc|Price:0.297|Chg%:+0.006 - TradingKey
GCTK|GlucoTrack Inc|Price:0.294|Chg%:+0.003 - TradingKey
GlucoTrack Inc (GCTK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GCTK|GlucoTrack Inc|Price:0.291|Chg%:-0.021 - TradingKey
GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GCTK|GlucoTrack Inc|Price:0.313|Chg%:+0.007 - TradingKey
GlucoTrack Inc (GCTK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
GlucoTrack (GCTK) stock rallies 16% after hours: Here's what is going on - MSN
Why Eva Live Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Sahm
GlucoTrack Inc. (GCTK) Holds Near Key Support After Modest DeclineDemand Zone - dars.gov.et
GlucoTrack Inc. (GCTK) Slips Slightly Amid Consolidation Near Key SupportVolume Spike Alerts - dars.gov.et
Press Release: Glucotrack, Inc. and Lōkahi Therapeutics(TM) Announce Strategic Financing Support From E.F. Hutton & Co. in Connection With Their Recently Completed Business Combination and Future Capital Markets Initiatives - Moomoo
Glucotrack completes bridge financing after merger - Investing.com UK
Glucotrack completes bridge financing after merger By Investing.com - Investing.com South Africa
Glucotrack, Inc. (NASDAQ: GCTK) sets 2026 vote on reverse split and warrants - Stock Titan
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing - The Manila Times
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on - GlobeNewswire
Glucotrack Gains Slightly on Bridge Financing Deal - Baystreet.ca
Glucotrack Secures Bridge Financing Following Lōkahi Merger to Support Growth and Future Capital Raises - citybiz
Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives - The Manila Times
Lōkahi students assess shelved clinical assets for new opportunities - Stock Titan
GlucoTrack (GCTK) Stock Rallies 16% After Hours: Here's What Is Going On - Benzinga
Glucotrack completes business combination with Lōkahi Therapeutics - Investing.com
GlucoTrack and Lokahi Therapeutics: Paul Goode Will Serve as Chief Technical Officer of Combined Co and CEO of CBGM Subsidiary - Moomoo
GlucoTrack and Lokahi Therapeutics: Erik Emerson Appointed CEO of Combined Co - Moomoo
UPDATEGlucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform - The Manila Times
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Glucotrack Completes Strategic Business Combination with Lōkahi Therapeutics to Form Publicly Listed Healthcare Platform - Quiver Quantitative
UPDATE – Glucotrack and Lōkahi Therapeutics Complete - GlobeNewswire
Glucotrack and Lōkahi Therapeutics Merge to Form Capital-Efficient Public Biopharma Platform Leveraging AI-Driven Asset Development 12 – Minichart - Minichart
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), upon the completion of the merger transaction between GlucoTrack, Inc. and Lokahi, the existing shareholders of Lokahi will receive shares equivalent to 19.99% of - Bitget
The board of Sprout Social, Inc. officially approved a personnel streamlining plan on July 8, 2026. - Bitget
Glucotrack (NASDAQ: GCTK) cedes 90% stake to Lokahi holders - Stock Titan
Glucotrack Merges With Lokahi Therapeutics; Former Holders to Own 90% Post-Conversion - TradingView
Glucotrack, Inc. (NASDAQ: GCTK) shifts control to Lokahi, adds $50M equity line - Stock Titan
Glucotrack Completes Lōkahi Therapeutics Business Combination, Creating AI-Driven Healthcare Platform - Yahoo Finance
Glucotrack Combines with Lōkahi Therapeutics - Medical Product Outsourcing
Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform - marketscreener.com
Glucotrack appoints Erik Emerson to Acquiror board following expansion - TradingView
Glucotrack (GCTK) Stock Is Trending Overnight — Here’s Why it Spiked Over 69% in After-Hours Session - Benzinga
Glucotrack and Lōkahi Therapeutics Complete Strategic - GlobeNewswire
Glucotrack Inc (GCTK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.37%
0.55%
자본화:
|
볼륨(24시간):